RAPTIVA Overview
EFALIZUMAB
- VIAL; SUBCUTANEOUS: 125MG/VIAL
Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).
| FDA application | Dosage Form | Strength | Marketing Status | Company |
|---|---|---|---|---|
| BLA #125075 | VIAL; SUBCUTANEOUS | 125MG/VIAL | Prescription | GENENTECH |
